| Open Document File Size: 758,23 KBShare Result on Facebook
City Sheffield / Cambridge / / Company BioMed Central Ltd / British Isles Lupus Assessment Group / / Continent Asia / / Country Mexico / Japan / United Kingdom / / / Facility University College / University College London / Imperial College / The Rayne Building / University Street / / IndustryTerm treatment for chronic refractory autoimmune diseases / computer software program / / MarketIndex BILAG / SLE Responder / Systemic Lupus Erythematosus Disease Activity / / MedicalCondition mean disease / systemic lupus erythematosus / lymphoma / neuropsychiatric systemic lupus erythematosus / seizures / Arthritis / follicular lymphoma / rheumatoid arthritis / nephritis / serious infections / proliferative lupus nephritis / complete nephritis / multiple sclerosis / extra-renal lupus / lymphoma / paediatric autoimmune diseases / lupus / autoimmune diseases / proteinuria / disease / chronic / less heterogeneous disease / follow-up Disease / lymphomas / cognitive dysfunction / active disease / mucocutaneous disease / systemic lupus / refractory lupus nephritis / lupus nephritis / moderate-to-severe disease / SLE / disorders / / MedicalTreatment premedication / Concomitant therapy / immunotherapy / Treatment protocols / Treatment protocol / immunosuppressive therapy / lymphocyte depletion / / Organization European League Against Rheumatism / University College London / Imperial College / Centre for Rheumatology / / Person Isenberg / / Position physician / author / Professor / patient/physician / Major / / Product methylprednisolone / acetaminophen / cyclophosphamide / C3 / prednisolone / EL / prednisone / azathioprine / / Region British Isles / Caribbean / / Technology EUROLUPUS protocol / antibodies / OCR / http / targeted immunotherapy / / URL http /
SocialTag |
Reddy et al. Arthritis Research & Therapy 2013, 15(Suppl 1):S2 http://arthritis-research.com/content/15/S1/S2 REVIEW B-cell depletion in SLE: clinical and trial experience